Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114627) titled 'Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients' on Aug. 4.
Study Type: Observational [Patient Registry]
Primary Sponsor: Erasmus Medical Center
Condition:
Solid Cancer
Gastric (Cardia, Body) Cancer
Esophageal Cancer
Colorectal Cancer (CRC)
Intervention:
Drug: Blood sampling for pharmacokinetics
Recruitment Status: Recruiting
Date of First Enrollment: February 18, 2025
Target Sample Size: 66
Countries of Recruitment:
Netherlands
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114627
Published by HT Digital Content Services with permission from Health Daily Digest....